NMT Medical Inc. said it will release data from the clinical trial of its StarFlex implant.
Analysis of data from the study, which aims to determine whether the device can help prevent stroke or ischemia from patent formane ovale, is due to be released during the fourth quarter of 2010. PFO is a defect in the septum separating the heart’s atrial chambers.
The StarFlex implant closes the defect, preventing venous blood from returning to the body without being oxygenated by the lungs.